{"disease":{"id":"tumor-invasiveness","name":"tumor invasiveness"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05589207","title":"Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion","phase":"","overall_status":"RECRUITING","enrollment_count":232,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT03742856","title":"A Multi-omics Study of Epithelial Ovarian Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Lei Li","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}